Health News Releases

  • Today August 23
April 25, 2020 10:00
BIO KOREA 2020 to Go Fully Digital with e-Conference, Online Meeting, and Virtual Exhibition from May 18 to 23
BIO KOREA 2020 International Convention, where global bio experts correspond, is shifting to an online-only event. BIO KOREA Organizing Committee has taken its final measures to execute a full digi
April 24, 2020 17:46
Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for Up to Approximately $670M USD
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescript
April 24, 2020 16:39
Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID Mortality in Some Regions
A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection induced by Japanese Encephalitis Vaccine (JEV) and/or Tick-Borne Encephalitis Va
April 24, 2020 13:37
Eurofins Technologies’ Range of Testing Kits for Serology-based Antibody Detection by ELISA in Patients Exposed to COVID-19 now Available to Order Online by Government Approved Clinical Laboratories Globally
In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody detection by ELISA of patients
EVIS X1 CV-1500 front
April 23, 2020 17:15
Olympus Launches EVIS X1, its Most Advanced Endoscopy System to Date
Olympus Corporation (President: Yasuo Takeuchi) today announced the launch of EVIS X1, its most advanced endoscopy system to date. The new system is to improve outcomes from disorders of the stomach,
Jesper Helmuth Larsen, CEO of AJ Vaccines
April 22, 2020 16:40
Breakthrough in the Global Battle Against Polio: AJ Vaccines Granted WHO Prequalification for New Polio Vaccine
Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a si
April 22, 2020 13:35
Evaluate BETADINE® Antiseptic Products’ Effectiveness Against SARS-CoV-2
Mundipharma today announced that it will embark on an ambitious series of studies both in vitro and in vivo to evaluate the effectiveness of its BETADINE® antiseptic products against the novel coronav
April 21, 2020 18:10
Boehringer Ingelheim’s Aservo® EquiHaler® wins Red Dot for outstanding design quality
Boehringer Ingelheim is proud to announce that its Aservo® EquiHaler® received a Red Dot Award for product design. Aservo® EquiHaler® is an inhalant therapy licensed for use in horses with severe equi
April 21, 2020 16:36
European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Boehringer Ingelheim today announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults.[2] The appro
April 21, 2020 16:32
VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus
Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq:CARA) today announced positive topline data from Cara’s KALM-2 pivotal phase-III trial of KOR
April 16, 2020 14:24
Ventilator Manufacturers Unite to Form Ventilator Training Alliance and Create App to Help Frontline Medical Workers During COVID-19 Pandemic
Several of the world’s ventilator manufacturers have formed a Ventilator Training Alliance (VTA) and partnered with Allego to create a mobile app that frontline medical providers can use to access a c
April 16, 2020 09:25
Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer
Samsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN®[1] (trastuzumab) for the treatment of HER2-overexpressing breas
April 15, 2020 13:47
Biolytic Introduces the Dr. Oligo 768XLc DNA RNA Synthesizer - Synthesizing 768 Oligos Just Got Faster
Biolytic Lab Performance Inc. unveiled its novel oligo synthesizer, the Dr. Oligo 768XLc, the most commercially advanced platform for high throughput nucleic acid synthesis. Designed to be operated in
April 14, 2020 13:53
Covetrus Integrates Telemedicine Capabilities Across Its Global Technology Portfolio
Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it is embedding secure video teleconferencing capabilities across the company’s global suite of
April 13, 2020 10:01
Masimo Announces Full Market Release of Masimo SafetyNet™, a Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts
Masimo (NASDAQ: MASI) announced today the full market release of Masimo SafetyNet™, an innovative, economically scalable cloud-based patient management solution designed to help clinicians care for pa
April 09, 2020 17:29
European Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ NSCLC
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ALUNBRIG (brigatinib) to include use as a mo
April 08, 2020 16:14
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
Boehringer Ingelheim has significantly stepped up its support to the fight against Covid-19. A Global Support Program has been set up to bring more financial relief, protective materials and medicine
April 08, 2020 13:54
St. Luke’s University Health Network One of the First in the World to Pilot Masimo SafetyNet™, a Remote Patient Management Solution, to Aid Hospitalized COVID-19 Patients
Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the netw
April 08, 2020 12:56
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) to develop a potential plasma-deri
April 08, 2020 09:00
Morinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacterium longum BB536 in Infant Formula
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received FDA GRAS (Generall
April 07, 2020 16:18
LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors
LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) 2061 for SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation fact
April 03, 2020 13:00
MAK's Oracle Water System Represents Device for Preventing COVID-19
“As it is harmless, I readily clean my hands using ‘Oracle Water’ after returning home, instead of other hand-detergents,” said a citizen of Daegu who was receiving the antiseptic solution at a commun
April 03, 2020 11:59
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To creat
April 02, 2020 14:11
EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-Treated COVID-19 Patients from the SISCO Study
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced initial preliminary findings from the Papa Giovanni XXIII Hospital sponsored SISCO (Siltuximab In
April 01, 2020 15:29
Takeda Adopts Executive Compensation Recoupment Policy
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced that its Board of Directors approved an executive compensation recoupment policy (“clawback policy”). The adoptio
25 per page50 per page75 per page100 per page